Piramal Pharma’s critical care division launches Chlorpromazine injection in US

Share it

Shares of Piramal Pharma Ltd ended at ₹242.65, up by ₹1.50, or 0.62% on the BSE.

Leave a Comment

Your email address will not be published. Required fields are marked *